Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Daniel E. Petrillo is active.

Publication


Featured researches published by Daniel E. Petrillo.


Tetrahedron Letters | 2002

Improved syntheses of α-BOC-aminoketones from α-BOC-amino-Weinreb amides using a pre-deprotonation protocol

Jinchu Liu; Norihiro Ikemoto; Daniel E. Petrillo; Joseph D. Armstrong

Abstract A general procedure was developed to prepare α-BOC-aminoketones in good yields from α-BOC-amino Weinreb amides containing an exchangeable amino proton. By first deprotonating this amino group using 1 equiv. of a simple alkyl Grignard base, only a stoichiometric amount, rather than a large excess, of the nucleophile was needed to prepare the ketone. This procedure is therefore more economical to run and the purification is easier.


Tetrahedron | 2001

Practical synthesis of a potent indolocarbazole-based, DNA topoisomerase inhibitor

Atsushi Akao; Shouichi Hiraga; Takehiko Iida; Asayuki Kamatani; Masashi Kawasaki; Toshiaki Mase; Takayuki Nemoto; Nobuya Satake; Steven A. Weissman; David M. Tschaen; Kai Rossen; Daniel E. Petrillo; Robert A. Reamer; Ralph P. Volante

Abstract DNA topoisomerase I inhibitors are currently under investigation as cancer chemotherapy agents of which indolocarbazole glycoside ( 1 ) has been identified as a promising candidate. A practical, scalable synthesis of 1 that limits the isolation of cytotoxic compounds to only that of the final product is described. The convergent process features a novel phase transfer-promoted glycosylation of aglycone core ( 4 ); subsequent hydrolysis provides anhydride ( 8 ). The hydrazine fragment ( 3 ), which is coupled with 8 , is synthesized via a modification of existing procedures. The coupled product ( 2 ) is subsequently hydrogenated to provide 1 in excellent purity via direct crystallization (>99.3 A%).


Archive | 2001

Phase transfer catalyzed glycosidation of an indolocarbazole

Daniel E. Petrillo; Steven A. Weissman; Shouichi Hiraga; Nobuya Satake; Kai Rossen


Archive | 2000

Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors

James R. Tata; Kevin T. Chapman; Joseph L. Duffy; Nancy J. Kevin; Yuan Cheng; Thomas A. Rano; Fengqi Zhang; Tracy Huening; Brian A. Kirk; Zhijian Lu; Subharekha Raghavan; Fred J. Fleitz; Daniel E. Petrillo; Joseph D. Armstrong; Richard J. Varsolona; David Askin; R. Scott Hoerrner; Robert Purick


Tetrahedron Letters | 2005

Approaches to installing a N-gem-dimethylmethylene-2-oxazolyl group and application to the synthesis of a second generation HIV protease inhibitor

Norihiro Ikemoto; Ross A. Miller; Fred J. Fleitz; Jinchu Liu; Daniel E. Petrillo; Joseph F. Leone; Joseph Laquidara; Benjamin Marcune; Sandor Karady; Joseph D. Armstrong; Ralph P. Volante


Archive | 2000

Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides and uses thereof

James R. Tata; Kevin T. Chapman; Joseph L. Duffy; Nancy J. Kevin; Yuan Cheng; Thomas A. Rano; Fengqi Zhang; Tracy Huening; Brian A. Kirk; Zhijian Lu; Subharekha Raghavan; Fred J. Fleitz; Daniel E. Petrillo; Joseph D. Armstrong; Richard J. Varsolona; David Askin; R. Scott Hoerrner; Robert Purick


Archive | 2002

Hydrohalide salts of an HIV protease inhibitor

Fred J. Fleitz; Daniel E. Petrillo; Yaling Wang; Russell Ferlita; David Dubost; Joseph D. Armstrong


Archive | 2001

Glycosidation d'un indolocarbazole catalysee par transfert de phase

Shouichi Hiraga; Daniel E. Petrillo; Kai Rossen; Nobuya Satake; Steven A. Weissman


Archive | 2000

Gamma-hydroxy-2- (fluoralkylaminocarbonyl) -1-piperazinpentanamide as HIV protease inhibitor

James R. Tata; Kevin T. Chapman; Joseph L. Duffy; Nancy J. Kevin; Yuan Cheng; Thomas A. Rano; Fengqi Zhang; Tracy Huening; Brian A. Kirk; Zhijian Lu; Subharekha Raghavan; Fred J. Fleitz; Daniel E. Petrillo; Joseph D. Armstrong; Richard J. Varsolona; David Askin; R. Scott Hoerrner; Robert Purick


Archive | 2000

Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides intervenant comme inhibiteurs de la protease du vih

James R. Tata; Kevin T. Chapman; Joseph L. Duffy; Nancy J. Kevin; Yuan Cheng; Thomas A. Rano; Fengqi Zhang; Tracy Huening; Brian A. Kirk; Zhijian Lu; Subharekha Raghavan; Fred J. Fleitz; Daniel E. Petrillo; Joseph D. Armstrong; Richard J. Varsolona; David Askin; R. Scott Hoerrner; Robert Purick

Collaboration


Dive into the Daniel E. Petrillo's collaboration.

Researchain Logo
Decentralizing Knowledge